Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study
Yacine Maringer, Melissa Zwick, Lisa Zieschang, Helmut R. Salih et al.
Citations
1 citations
Journal
The Lancet Haematology
Topics
Chronic Lymphocytic Leukemia Research
Field-Weighted Citation Impact (FWCI)
36.93
article
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study
Yacine Maringer, Melissa Zwick, Lisa Zieschang, Helmut R. Salih, Ariane Lehmann, Stefan Wirths, Melek Tutku Oezbek, Annika Nelde, Jonas S. Heitmann, Marcel Wacker, Anna-Sophia Baur, Monika Denk, Peter Martus, Jens Bauer, Geoffroy Andrieux, Marion Richter, Anna Dengler, Christopher Hackenbruch, Juliane S. Walz, Christine Kammer, Christopher Krolla, M Polster, M. Brüggemann, Marina Pumptow, Melanie Boerries, Natalie Köhler, Marissa L Dubbelaar, Naomi Hoenisch-Gravel, Susanne Jung, Hans-Georg Rammensee, Maddalena Marconato
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet HaematologyVol. 13(2)
Institutions
University of Freiburg (DE), University Medical Center Freiburg (DE), University Hospital Schleswig-Holstein (DE), University Children's Hospital Tübingen (DE), University of Tübingen (DE), University of Lübeck (DE)